APA

Mannioui A., Vauzanges Q., Fini J. B., Henriet E., Sekizar S., Azoyan L., Thomas J. L., Pasquier D. D., Giovannangeli C., Demeneix B., Lubetzki C. & Zalc B. (20190909). The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Mannioui Abdelkrim, Vauzanges Quentin, Fini Jean Baptiste, Henriet Esther, Sekizar Somya, Azoyan Loris, Thomas Jean Léon, Pasquier David Du, Giovannangeli Carine, Demeneix Barbara, Lubetzki Catherine and Zalc Bernard. 20190909. The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Mannioui A., Vauzanges Q., Fini J. B., Henriet E., Sekizar S., Azoyan L., Thomas J. L., Pasquier D. D., Giovannangeli C., Demeneix B., Lubetzki C. and Zalc B. (20190909). The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Mannioui Abdelkrim, Vauzanges Quentin, Fini Jean Baptiste, Henriet Esther, Sekizar Somya, Azoyan Loris, Thomas Jean Léon, Pasquier David Du, Giovannangeli Carine, Demeneix Barbara, Lubetzki Catherine and Zalc Bernard. The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination. : Multiple sclerosis (Houndmills, Basingstoke, England). 20190909.